Antibody Based Therapy in Coronary Artery Disease and Heart Failure
Journal Title: Heart Research – Open Journal - Year 2017, Vol 4, Issue 2
Abstract
The function of the immune system is to protect the host against disease. Antibodies are a key part of the adaptive response, recognising specific antigens and invading pathogens and marking them for destruction or blocking their activities. A mechanistic and molecular understanding of this process has allowed researchers to harness their natural function. They are now routinely used as a diagnostic tool in the clinic and in research to investigate pathological signalling. More recently, antibodies have been utilised for another application – therapy. Antibody based therapy is one of the newest and fastest growing with nearly 70 approved drugs to date and over 1000 in clinical trials. Investment from the pharmaceutical sector shows no signs of abating and this technology is now widely accepted for treating cancer, autoimmune and infectious diseases. In the context of the cardiovascular system however, antibody therapies are relatively limited. This review summarises the monoclonal antibodies approved for clinical use or currently in clinical trials for treating cardiovascular disorders. Presently, coronary artery disease, heart failure and transplant are the main indications, and monoclonal antibody therapies are discussed in the context of their specific applications.
Authors and Affiliations
Lorna R. Fiedler
Keywords
Related Articles
- EP ID EP558218
- DOI 10.17140/HROJ-4-140
- Views 152
- Downloads 0
Where are Cell-Based Therapies Heading? Current Limitations and Future Directions
Congestive heart failure (CHF) secondary to chronic coronary artery disease is a major cause of morbidity and mortality worldwide. Its prevalence is increasing despite advances in medical and device therapies. Adult stem...
Baseline Visual Acuity of Women with Diabetic Macular Edema is Worse than Men: A Case-Control Study
Purpose: To compare the baseline visual and anatomical parameters between the woman and men with diabetic macular edema (DME) who underwent intravitreal ranibizumab treatment. Materials and Methods: This was a retrospect...
Patient Quality Measures: The Necessary Paradigm Shifts in Medicine
Improving patient quality measures is a complex task. It involves more than simply telling caregivers to adopt new practices. Rather, it uses current research and tools to bring about creating changes in workplace attitu...
E-Care Project: A Promising E-Platform for Optimizing Management of Chronic Heart Failure and Other Chronic Diseases
Monitoring patients with heart failure by using telemedicine systems is a potential means for optimizing the management of these patients. The E-care project is developing an “intelligent” communicative platform enabling...
Saroglitazar: A New Drug to Treat Diabetic Hypertriglyceridemia
Dyslipidemia alone has been considered as one of the major modifiable risk factor for cardiovascular diseases (CVD) accounting for 50% of the 1st myocardial infarction (MI) cases worldwide.1 A recent epidemiological sur...